Here is a rewritten version of the article in my own words:
The legal cannabis industry is on the cusp of significant change, with the US administration considering reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act. This move could have a profound impact on the industry, potentially reducing tax rates, increasing profitability, and opening up access to institutional investors and lower-cost investments.
Despite the uncertainty surrounding reclassification, analysts have identified 12 marijuana stocks that offer significant upside potential. These stocks were selected based on their potential for growth and their ability to weather any changes in the regulatory environment.
The list includes Aurora Cannabis Inc., which has launched a new platform for healthcare professionals to access peer-reviewed clinical insights on medicinal cannabis treatments. The platform, called Physician Experience Platform (PEP), is initially available in several countries and aims to provide healthcare professionals with access to real-world case studies.
Other notable stocks on the list include Turning Point Brands, Inc., which has launched a new product line of fine cut wintergreen tobacco, and The Scotts Miracle-Gro Company, which has made significant strides in sustainability and environmental responsibility.
These stocks offer a range of investment opportunities, from established companies with a strong track record to newer entrants in the market. While the future of the cannabis industry is uncertain, these stocks have the potential to deliver significant returns for investors.
It’s worth noting that our research has shown that imitating the top stock picks of the best hedge funds can be a profitable strategy. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points.
